Skip to content

Company research

Tishman Speyer Innovation Corp. II

CIK 1832737Updated Sep 27, 2026

Securities

Historical securities (3)

TSIB · NASDAQ · equity · closed Nov 30, 2022 TSIBU · NASDAQ · unit · closed Nov 30, 2022 TSIBW · NASDAQ · warrant · closed Nov 30, 2022

Name history

TS Innovation II Corp. · through Nov 25, 2020

TSIB price & chart

Provider market data

Historical security

This listing closed Nov 30, 2022. Live provider charts are shown only for current listings.

In the news

No coverage from other publishers is available.

Recent filings

15-12G filing
15-12G · 2022-12-12 · 0001193125-22-302557
25-NSE filing
25-NSE · 2022-12-01 · 0001354457-22-000672
8-K filing
8-K · 2022-11-29 · 0001193125-22-294463
10-Q filing
10-Q · 2022-11-10 · 0001193125-22-282766
DEF 14A filing
DEF 14A · 2022-11-08 · 0001193125-22-280281

Show 5 more recent filings

PRE 14A filing
PRE 14A · 2022-10-24 · 0001193125-22-267615
SC 13G filing
SC 13G · 2022-08-26 · 0001062993-22-018794
10-Q filing
10-Q · 2022-08-10 · 0001193125-22-216368
10-Q filing
10-Q · 2022-05-13 · 0001193125-22-150165
10-K filing
10-K · 2022-03-29 · 0001193125-22-088238

Financials

FY 2021 · USD

Revenue— · FY 2021

Net income4,302,374USD · FY 2021

Source

10-K · 2022-03-29 · 0001193125-22-088238

2021-01-01 to 2021-12-31

Assets300,942,868USD · FY 2021

Source

10-K · 2022-03-29 · 0001193125-22-088238

As of 2021-12-31

Cash546,159USD · FY 2021

Source

10-K · 2022-03-29 · 0001193125-22-088238

As of 2021-12-31

Operating income-3,144,397USD · FY 2021

Source

10-K · 2022-03-29 · 0001193125-22-088238

2021-01-01 to 2021-12-31

Diluted EPS— · FY 2021

Some figures are unavailable for this reporting year.

balance sheet · annual statements

Line item	FY 2021	FY 2020
ASSETS
AssetsUSD	300,942,868 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	230,000 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD	546,159 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	1,975 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Assets, CurrentUSD	887,173 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	230,000 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
LIABILITIES AND EQUITY
LiabilitiesUSD	22,309,742 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	205,998 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Stockholders’ equity:
Additional Paid in CapitalUSD	0 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	24,137 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Retained Earnings (Accumulated Deficit)USD	-21,367,624 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	-998 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Stockholders' Equity Attributable to ParentUSD	-21,366,874 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	24,002 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Liabilities and EquityUSD	300,942,868 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	230,000 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Current liabilities:
Liabilities, CurrentUSD	2,565,470 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	205,998 Source 10-Q · 2021-05-25 · 0001193125-21-171947 As of 2020-12-31
Additional Financial Items
Redeemable Noncontrolling Interest, Equity, Common, Carrying AmountUSD	300,000,000 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2021-12-31	0 Source 10-K · 2022-03-29 · 0001193125-22-088238 As of 2020-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements

Line item	FY 2021
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD	2,460,186 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Net Cash Provided by (Used in) Operating ActivitiesUSD	-960,179 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD	-300,000,000 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD	301,504,363 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Additional Financial Items
Income Tax Expense (Benefit)USD	0 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Investment Income, InterestUSD	16,455 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Net Income (Loss) Attributable to ParentUSD	4,302,374 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Nonoperating Income (Expense)USD	7,446,771 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Operating Costs and ExpensesUSD	3,144,397 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Proceeds from Issuance of Common StockUSD	0 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements

Line item	FY 2021
Operating Income (Loss)USD	-3,144,397 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Income Tax Expense (Benefit)USD	0 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Net Income (Loss) Attributable to ParentUSD	4,302,374 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Additional Financial Items
Investment Income, InterestUSD	16,455 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Nonoperating Income (Expense)USD	7,446,771 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31
Operating Costs and ExpensesUSD	3,144,397 Source 10-K · 2022-03-29 · 0001193125-22-088238 2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.